Ipsen Study Director [clinicaltrials_resource:16f42f43ed2aaa14036bb537976fe2e2]
To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Following Stroke [clinicaltrials:NCT01020500]Dysport® Adult Lower Limb Spasticity Study [clinicaltrials:NCT01249404]Dysport® Pediatric Lower Limb Spasticity Study [clinicaltrials:NCT01249417]Dysport® Adult Lower Limb Spasticity Follow-on Study [clinicaltrials:NCT01251367]Dysport® Pediatric Lower Limb Spasticity Follow-on Study [clinicaltrials:NCT01251380]Study Comparing Short Term Efficacy of Dysport® and Dysport RU® to Placebo, and to Assess Efficacy and Safety of Dysport RU® of Subjects With Cervical Dystonia [clinicaltrials:NCT01261611]Dysport® Adult Upper Limb Spasticity [clinicaltrials:NCT01313299]Dysport® Adult Upper Limb Spasticity Extension Study [clinicaltrials:NCT01313312]DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia [clinicaltrials:NCT01314365]Safety and Efficacy Study of Dysport RU® and Glabellar Lines [clinicaltrials:NCT01333397]clinicaltrials:NCT01357980BN80927 in Patients With Advanced Malignant Solid Tumors [clinicaltrials:NCT01435096]Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve the Appearance of Moderate to Severe Glabellar Lines [clinicaltrials:NCT02353871]Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport® [clinicaltrials:NCT02353897]Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines [clinicaltrials:NCT02493946]
overall official [clinicaltrials_vocabulary:overall-official]
Ipsen Study Director [clinicaltrials_resource:16f42f43ed2aaa14036bb537976fe2e2]
Bio2RDF identifier
16f42f43ed2aaa14036bb537976fe2e2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:16f42f43ed2aaa14036bb537976fe2e2
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
Clinical.trials@ipsen.com
clinical.trials@ipsen.com
last name [clinicaltrials_vocabulary:last-name]
Ipsen Study Director
phone [clinicaltrials_vocabulary:phone]
clinical.trials@ipsen.com
role [clinicaltrials_vocabulary:role]
Study Director
identifier
clinicaltrials_resource:16f42f43ed2aaa14036bb537976fe2e2
title
Ipsen Study Director
@en
type
label
Ipsen Study Director [clinicaltrials_resource:16f42f43ed2aaa14036bb537976fe2e2]
@en